USPH Stock Overview

Operates and manages outpatient physical therapy clinics. More details

USPH fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	4/6
Past Performance	4/6
Financial Health	4/6
Dividends	3/6

Rewards

Trading at 56.4% below our estimate of its fair value

Earnings are forecast to grow 22.48% per year

Earnings grew by 52.9% over the past year

Analysts in good agreement that stock price will rise by 49.7%

Risk Analysis

Significant insider selling over the past 3 months

Dividend of 2.49% is not well covered by earnings

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

U.S. Physical Therapy

Analyst Price Target

Consensus Narrative from 6 Analysts

AI Adoption And Metro PT Acquisition Will Boost Operational Efficiency And Market Expansion

Key Takeaways Positive patient feedback and innovative AI-driven systems are set to boost revenue growth and operational efficiency, enhancing net margins. Strategic acquisitions and industry diversification efforts are expected to expand market presence and revenue streams, driving overall earnings growth.

View narrative

US$108.33

33.2% undervalued

10.44%

Revenue growth p.a.

7 days ago

View U.S. Physical Therapy Community

U.S. Physical Therapy, Inc. Competitors

National HealthCare

NYSEAM:NHC

US$1.4b

Ardent Health Partners

NYSE:ARDT

US$2.0b

PACS Group

NYSE:PACS

US$1.7b

Select Medical Holdings

NYSE:SEM

US$2.2b

Price History & Performance

Summary of share price highs, lows and changes for U.S. Physical Therapy
Historical stock prices
Current Share Price	US$72.38
52 Week High	US$112.52
52 Week Low	US$69.99
Beta	1.51
1 Month Change	-10.66%
3 Month Change	-18.41%
1 Year Change	-32.48%
3 Year Change	-28.22%
5 Year Change	11.54%
Change since IPO	2,895.03%

Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?

Mar 24

U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Mar 01

U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly

Feb 28

Recent updates

Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?

Mar 24

U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Mar 01

U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly

Feb 28

Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal

Jan 03

Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price

Nov 09

Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion

Sep 14 Innovations in recruitment and operational efficiencies are set to bolster net margins despite a tight labor market and high costs.

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

Aug 07

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Jul 17

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

Jun 04

There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

May 21

U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

May 11

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

May 05

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

Apr 21

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Apr 07

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Mar 04

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Dec 23

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Dec 07

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Oct 13

Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

Aug 01

U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)

Jul 19

At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

May 07

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price

Apr 16

U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet

Apr 01

Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital

Mar 04

U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook

Feb 23

U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit

Feb 12

Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?

Jan 24

We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt

Dec 20

Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching

Dec 05

Shareholder Returns

	USPH	US Healthcare	US Market
7D	-1.2%	1.5%	-3.0%
1Y	-32.5%	2.6%	7.5%

Return vs Industry: USPH underperformed the US Healthcare industry which returned -2.6% over the past year.

Return vs Market: USPH underperformed the US Market which returned 6.1% over the past year.

Price Volatility

Is USPH's price volatile compared to industry and market?
USPH volatility
USPH Average Weekly Movement	3.4%
Healthcare Industry Average Movement	6.6%
Market Average Movement	6.4%
10% most volatile stocks in US Market	16.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: USPH has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: USPH's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1990	5,531	Chris Reading	www.usph.com

U.S. Physical Therapy, Inc. operates and manages outpatient physical therapy clinics. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

U.S. Physical Therapy, Inc. Fundamentals Summary

How do U.S. Physical Therapy's earnings and revenue compare to its market cap?
USPH fundamental statistics
Market cap	US$1.10b
Earnings (TTM)	US$27.73m
Revenue (TTM)	US$664.43m

39.7x

P/E Ratio

1.7x

P/S Ratio

Is USPH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
USPH income statement (TTM)
Revenue	US$664.43m
Cost of Revenue	US$518.30m
Gross Profit	US$146.13m
Other Expenses	US$118.40m
Earnings	US$27.73m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.83
Gross Margin	21.99%
Net Profit Margin	4.17%
Debt/Equity Ratio	20.2%

How did USPH perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

96%

Payout Ratio

Does USPH pay a reliable dividends?

See USPH dividend history and benchmarks

When do you need to buy USPH by to receive an upcoming dividend?
U.S. Physical Therapy dividend dates
Ex Dividend Date	Mar 14 2025
Dividend Pay Date	Apr 11 2025
Days until Ex dividend	20 days
Days until Dividend pay date	8 days

Does USPH pay a reliable dividends?

See USPH dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/01 13:34
End of Day Share Price	2025/04/01 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

U.S. Physical Therapy, Inc. is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Michael Petusky	Barrington Research Associates, Inc.
Joanna Sylvia Gajuk	BofA Global Research
null null	Burkenroad Reports

USPH Stock Overview

Rewards

Risk Analysis

AI Adoption And Metro PT Acquisition Will Boost Operational Efficiency And Market Expansion

U.S. Physical Therapy, Inc. Competitors

NYSEAM:NHC

US$1.4b

NYSE:ARDT

US$2.0b

NYSE:PACS

US$1.7b

NYSE:SEM

US$2.2b

Price History & Performance

Recent News & Updates

Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?

Fourth quarter dividend increased to US$0.45

U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

U.S. Physical Therapy, Inc. Raises Quarterly Dividend and Declares Quarterly Dividend for the First Quarter of 2025, Payable on April 11, 2025

Recent updates

Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?

Fourth quarter dividend increased to US$0.45

U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

U.S. Physical Therapy, Inc. Raises Quarterly Dividend and Declares Quarterly Dividend for the First Quarter of 2025, Payable on April 11, 2025

U.S. Physical Therapy, Inc. to Report Q4, 2024 Results on Feb 27, 2025

Insufficient new directors

Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal

New minor risk - Insider selling

President & COO recently sold US$192k worth of stock

Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price

Upcoming dividend of US$0.44 per share

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Now 20% undervalued after recent price drop

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

Chairman & CEO notifies of intention to sell stock

Chairman & CEO recently sold US$212k worth of stock

There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

Chief Operating Officer - East recently sold US$261k worth of stock

U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

First quarter dividend of US$0.44 announced

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Executive VP recently sold US$213k worth of stock

Executive VP notifies of intention to sell stock

Price target increased by 9.0% to US$119

Chief Operating Officer - West recently sold US$274k worth of stock

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Upcoming dividend of US$0.44 per share

Fourth quarter dividend increased to US$0.44

New minor risk - Profit margin trend

Full year 2023 earnings: EPS misses analyst expectations

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Now 20% undervalued after recent price drop

Price target decreased by 9.6% to US$110

Consensus EPS estimates fall by 10%

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

Price target decreased by 7.9% to US$118

Now 20% undervalued after recent price drop

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?

U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital